HLNE Stock Forecast 2025-2026
Distance to HLNE Price Targets
HLNE Price Momentum
10 Quality Stocks Worth Considering Now
Researching Hamilton Lane (HLNE) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on HLNE and similar high-potential opportunities.
Latest HLNE Stock Price Targets & Analyst Predictions
Based on our analysis of 12 Wall Street analysts, HLNE has a neutral consensus with a median price target of $155.00 (ranging from $136.00 to $176.00). The overall analyst rating is Buy (6.3/10). Currently trading at $148.01, the median forecast implies a 4.7% upside. This outlook is supported by 1 Buy, 4 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HLNE Analyst Ratings
HLNE Price Target Range
Latest HLNE Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HLNE.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 14, 2025 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $157.00 |
| Apr 8, 2025 | Wells Fargo | Michael Brown | Equal-Weight | Maintains | $147.00 |
| Mar 20, 2025 | Wells Fargo | Michael Brown | Equal-Weight | Maintains | $152.00 |
| Feb 5, 2025 | Wells Fargo | Michael Brown | Equal-Weight | Maintains | $169.00 |
| Feb 5, 2025 | Keefe, Bruyette & Woods | Kyle Voigt | Market Perform | Maintains | $168.00 |
| Jan 14, 2025 | Wells Fargo | Michael Brown | Equal-Weight | Maintains | $163.00 |
| Jan 13, 2025 | Keefe, Bruyette & Woods | Kyle Voigt | Market Perform | Maintains | $158.00 |
| Jan 6, 2025 | Goldman Sachs | Alexander Blostein | Sell | Downgrade | $139.00 |
| Dec 20, 2024 | Keefe, Bruyette & Woods | Kyle Voigt | Market Perform | Maintains | $167.00 |
| Dec 12, 2024 | Wells Fargo | Michael Brown | Equal-Weight | Maintains | $194.00 |
| Nov 11, 2024 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $190.00 |
| Nov 7, 2024 | Keefe, Bruyette & Woods | Kyle Voigt | Market Perform | Maintains | $215.00 |
| Nov 7, 2024 | JP Morgan | Ken Worthington | Neutral | Maintains | $175.00 |
| Oct 22, 2024 | UBS | Adam Beatty | Neutral | Maintains | $185.00 |
| Oct 10, 2024 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $182.00 |
| Oct 9, 2024 | Wells Fargo | Michael Brown | Equal-Weight | Maintains | $170.00 |
| Oct 3, 2024 | Goldman Sachs | Alexander Blostein | Neutral | Maintains | $147.00 |
| Sep 12, 2024 | Wells Fargo | Michael Brown | Equal-Weight | Initiates | $156.00 |
| Aug 21, 2024 | UBS | Adam Beatty | Neutral | Maintains | $150.00 |
| Aug 7, 2024 | JP Morgan | Ken Worthington | Neutral | Maintains | $134.00 |
Hamilton Lane Inc. (HLNE) Competitors
The following stocks are similar to Hamilton Lane based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Hamilton Lane Inc. (HLNE) Financial Data
Hamilton Lane Inc. has a market capitalization of $8.21B with a P/E ratio of 26.6x. The company generates $691.66M in trailing twelve-month revenue with a 31.1% profit margin.
Revenue growth is +34.3% quarter-over-quarter, while maintaining an operating margin of +45.0% and return on equity of +42.7%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Hamilton Lane Inc. (HLNE) Business Model
About Hamilton Lane Inc.
Provides private markets investment management services.
Hamilton Lane Inc. generates revenue by offering tailored investment solutions, data-driven insights, and advisory services to institutional investors such as pension plans, endowments, and family offices. The firm facilitates capital flow into private equity, infrastructure, real estate, and credit markets, allowing clients access to unique investment opportunities.
Headquartered in Bala Cynwyd, Pennsylvania, Hamilton Lane is recognized for its expertise in navigating complex market environments and has a significant global reach, positioning itself as a key player in the private markets ecosystem.
Company Information
Sector
Financial Services
Industry
Asset Management
Employees
700
CEO
Mr. Erik R. Hirsch
Country
United States
IPO Year
2017
Website
www.hamiltonlane.comHamilton Lane Inc. (HLNE) Latest News & Analysis
Latest News
PAX Health has acquired Richardson Psychiatric Associates, expanding its behavioral healthcare services for all age groups. The company is backed by HCAP Partners and Hamilton Lane (Nasdaq:HLNE).
PAX Health's acquisition of Richardson Psychiatric Associates expands its service offerings and market reach, potentially enhancing revenue and growth prospects, which may positively impact investor sentiment.
Hamilton Lane (HLNE) saw a rise in share price with above-average trading volume, but recent earnings estimate revisions indicate potential weakness ahead.
The surge in Hamilton Lane's share price on high volume indicates investor interest, but declining earnings estimates may signal potential weakness ahead, affecting future performance.
Hamilton Lane Partners with Dalan Real Estate to Acquire $74 million NYC Multifamily Portfolio
30 days agoHamilton Lane (Nasdaq: HLNE) has announced an investment in a portfolio of four multifamily assets located in lower Manhattan.
Hamilton Lane's investment in multifamily assets in lower Manhattan signals confidence in the real estate market, potentially influencing property values and attracting further investment in the area.
Hamilton Lane has launched the Hamilton Lane Private Infrastructure Fund (HLPIF), allowing retail investors to access infrastructure assets via a tokenized format on Republic's platform.
The launch of HLPIF via a tokenized format provides retail investors with new access to infrastructure assets, potentially increasing demand for Hamilton Lane's offerings and market competitiveness.
Hamilton Lane's 2025 Market Overview indicates short-term concerns in private markets but highlights strong long-term growth potential, particularly in evergreen investments.
The report signals short-term risks in private markets, but highlights long-term growth potential, influencing investment strategies and risk assessments for investors.
Hamilton Lane Launches Private Secondary Fund in the U.S., Further Expanding Global Evergreen Platform
1 month agoHamilton Lane launched the Hamilton Lane Private Secondary Fund, an evergreen investment vehicle for U.S. accredited investors, leveraging over 24 years of experience in the secondary market.
The launch of Hamilton Lane's Private Secondary Fund signals confidence in long-term growth trends, potentially attracting more capital and enhancing the firm’s market position, impacting investor returns.
Frequently Asked Questions About HLNE Stock
What is Hamilton Lane Inc.'s (HLNE) stock forecast for 2025?
Based on our analysis of 12 Wall Street analysts, Hamilton Lane Inc. (HLNE) has a median price target of $155.00. The highest price target is $176.00 and the lowest is $136.00.
Is HLNE stock a good investment in 2025?
According to current analyst ratings, HLNE has 1 Buy ratings, 4 Hold ratings, and 1 Sell ratings. The stock is currently trading at $148.01. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HLNE stock?
Wall Street analysts predict HLNE stock could reach $155.00 in the next 12 months. This represents a 4.7% increase from the current price of $148.01. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Hamilton Lane Inc.'s business model?
Hamilton Lane Inc. generates revenue by offering tailored investment solutions, data-driven insights, and advisory services to institutional investors such as pension plans, endowments, and family offices. The firm facilitates capital flow into private equity, infrastructure, real estate, and credit markets, allowing clients access to unique investment opportunities.
What is the highest forecasted price for HLNE Hamilton Lane Inc.?
The highest price target for HLNE is $176.00 from at , which represents a 18.9% increase from the current price of $148.01.
What is the lowest forecasted price for HLNE Hamilton Lane Inc.?
The lowest price target for HLNE is $136.00 from at , which represents a -8.1% decrease from the current price of $148.01.
What is the overall HLNE consensus from analysts for Hamilton Lane Inc.?
The overall analyst consensus for HLNE is neutral. Out of 12 Wall Street analysts, 1 rate it as Buy, 4 as Hold, and 1 as Sell, with a median price target of $155.00.
How accurate are HLNE stock price projections?
Stock price projections, including those for Hamilton Lane Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.